Adjuvant trastuzumab in HER2-positive breast cancer
- PMID: 22335748
- DOI: 10.1056/NEJMc1112823
Adjuvant trastuzumab in HER2-positive breast cancer
Comment on
-
Adjuvant trastuzumab in HER2-positive breast cancer.N Engl J Med. 2011 Oct 6;365(14):1273-83. doi: 10.1056/NEJMoa0910383. N Engl J Med. 2011. PMID: 21991949 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous